Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 215

Trial Status

Completed10
Terminated5
Other1

Role Distribution

Principal Investigator16
PI Rate100%

Activity Timeline

Clinical Trials (16)

NCT05254418Phase 2Completed
Effects of GLP1-RA on Ectopic Fat Deposition in Chronic Kidney Disease
Chronic Kidney Diseases
PrincipalinvestigatorStart date: 2022-03-15
NCT00179205Phase 2Terminated
Complementary Intradialytic Nutritional Supplementation in Dialysis Patients
End Stage Renal Disease
Principalinvestigator
NCT00237718Phase 2Completed
Provision of Antioxidant Therapy in Hemodialysis (PATH) Study
End-stage Renal Disease
Principalinvestigator
NCT00367198Phase 2Terminated
Protein Supplementation in Dialysis Patients
End Stage Renal Disease
Principalinvestigator

Showing 10 of 16 trials

Research Network

Collaboration Network

3 collaborators·2 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Vanderbilt University Medical Center

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (16)

Showing 16 of 16 trials

NCT05254418Phase 2PrincipalInvestigator

Effects of GLP1-RA on Ectopic Fat Deposition in Chronic Kidney Disease

Chronic Kidney Diseases
Completed
NCT00179140Phase 2PrincipalInvestigator

The Effects of Protein Supplementation and Resistance Exercise in Hemodialysis Patients

End Stage Renal Disease
Completed
NCT00179153Phase 2PrincipalInvestigator

Improving The Nutritional Status Of The Malnourished Chronic Hemodialysis Patients In The State Of Tennessee

End Stage Renal Disease
Completed
NCT00179166Phase 2PrincipalInvestigator

Assessment of Metabolic Response in Critically Ill Patients With Acute Renal Failure

Acute Renal Failure
Terminated
NCT00179179Phase 2PrincipalInvestigator

The Effects of Nutrition Supplementation and Resistance Exercise During Hemodialysis

End Stage Renal Disease
Completed
NCT00179205Phase 2PrincipalInvestigator

Complementary Intradialytic Nutritional Supplementation in Dialysis Patients

End Stage Renal Disease
Terminated
NCT00179218Phase 2PrincipalInvestigator

The Effects of Resistance Exercise and Protein Supplementation in Hemodialysis Patients

End Stage Renal Disease
Completed
NCT00237718Phase 2PrincipalInvestigator

Provision of Antioxidant Therapy in Hemodialysis (PATH) Study

End-stage Renal Disease
Completed
NCT00244075Phase 2PrincipalInvestigator

Effects of Nutritional Supplementation on Protein and Energy Homeostasis in Malnourished Chronic Hemodialysis Patients

End Stage Renal Disease
Completed
NCT00367198Phase 2PrincipalInvestigator

Protein Supplementation in Dialysis Patients

End Stage Renal Disease
Terminated
NCT00368017Phase 2PrincipalInvestigator

Metabolic Effects of Thiazolidinediones in Chronic Kidney Disease

Chronic Kidney Disease
Terminated
NCT00581269Phase 2PrincipalInvestigator

Dietary Intervention and Exercise Training (DIET) in Moderate to Severe Chronic Kidney Disease

Chronic Kidney Disease
Terminated
NCT00592410Phase 2PrincipalInvestigator

The Effects of Intensive Insulin on Somatic and Visceral Protein Turnover in Acute Kidney Injury (AKI)

Acute Renal Failure
Withdrawn
NCT00655525Phase 2PrincipalInvestigator

Omega-3 Fatty Acid Administration in Dialysis Patients

End Stage Renal Disease
Completed
NCT00656032Phase 2PrincipalInvestigator

Vitamin D, Insulin Resistance and Inflammation in ESRD

End Stage Renal Disease
Completed
NCT01119196Not ApplicablePrincipalInvestigator

The Measurement of Insulin Resistance in Peritoneal Dialysis Patients

End Stage Renal Disease
Completed

All 16 trials loaded